MedTrace Logo

Non-invasive Hemoglobin Monitoring in Congenital Heart Diseased Children

NCT03248830 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2019-10-01

No results posted yet for this study

Summary

The investigators will evaluate the accuracy of non-invasive hemoglobin monitor (Sp-Hb) compared to traditional laboratory hemoglobin (Lab-Hb) in children with congenital heart disease. The investigators will also compare the accuracy of Sp-Hb in cyanotic children to acyanotic children.

Conditions

  • Congenital Heart Disease

Interventions

DEVICE

radical-7 pulse co-oximeter

Radical-7 pulse co-oximter will be applied to the patient through a special probe attached the the patient digit to measure blood hemoglobin

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Mukhtar, Professor · Head of research committee section in anesthesia department

Eligibility

Min Age
1 Month
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-20
Primary Completion
2019-08-01
Completion
2019-09-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03248830 on ClinicalTrials.gov